-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.Börse Börse StuttgartSymbol 0C8-
CatalentBörse NYSE New York Stock ExchangeISIN US1488061029 WKN: A112H2Symbol CTLT
-
CatalentBörse Börse FrankfurtSymbol 0C8
-
CatalentBörse Börse BerlinSymbol 0C8
-
CATALENT INCBörse Quotrix System der Börse DüsseldorfSymbol 0C8
-
CATALENT INCBörse Gettex System der Börse MünchenSymbol 0C8
-
CATALENT INCBörse Tradegate System der Deutsche Börse AG (60%)Symbol 0C8
-
CATALENT INCBörse Börse StuttgartSymbol 0C8
-
Symbol 0C8
-
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
19.434.817.536 oder 15.653.000.000
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
14.000 oder 19.000 Mitarbeiter
Aktionärsstruktur der Catalent, Inc
Portrait der Catalent Aktie
Das Unternehmen Catalent, Inc aus USA beschäftigt 16.500 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Sonstige Branche, Biotechnologie tätig.
Das Unternehmen Catalent, Inc ist in mehr als 33 ETFs enthalten und somit eine vermutlich durchschnittlich bekannte Aktie. Der Spitzenreiter VanEck Vectors Pharmaceutical ETF gewichtet Catalent mit 4,57% im ETF.
Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Catalent Anleihen auf einen Blick.
Entdecke die 6 ETFs in denen Catalent, Inc am höchsten gewichtet ist Insgesamt in 33 ETFs enthalten
Dir gefallen die Informationen zu Catalent?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Dir gefallen die Informationen zu Catalent?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Dir gefallen die Informationen zu Catalent?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Dir gefallen die Informationen zu Catalent?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
58 News & Informationen zur Catalent Aktie
ETFs with Investments in SP500 Winners of 8
Three ETF's per winner (when available) ETF Ticker | % invested in Winner | ETF Full Name Industrials: ETFs investing in Quanta Services Inc GRID- …
A Look Into Catalent's Price Over Earnings
In the current market session, Catalent Inc. (NYSE:CTLT) is trading at $126.21, after a 0.1% drop. However, over the past month, the stock …
Catalent's Debt Overview
Shares of Catalent (NYSE:CTLT) rose by 23.76% in the past three months. Before having a look at the importance of debt, let us look at how much debt …
Polar Asset Management Partners Inc. Buys Genius Sports, Anaplan Inc, Precision Drilling Corp, Sells Activision Blizzard Inc, Porch Group Inc, QuantumScape Corp
GuruFocus Article or News written by insider and the topic is about:
Cathie Wood is Getting Rid of These 10 Stocks
Cathie Wood, the chief of New York-based ARK Investment Management, has become famous on Wall Street in recent years for her aggressive bets on technology stocks.
Catalent (CTLT) to Report Q4 Earnings: What's in Store?
Catalent's (CTLT) Biologics segment is likely to have maintained its momentum, thereby aiding Q4 results.
Pfizer, Moderna get EU nod for boosting mRNA COVID-19 vaccine output
Europe’s medicines regulator has approved additional manufacturing sites for mRNA-based coronavirus vaccines developed by Pfizer-BioNTech and Moderna to help…
Eversept Partners, LLC Buys Bristol-Myers Squibb Company, Community Health Systems Inc, Organon, Sells , TG Therapeutics Inc, GlaxoSmithKline PLC
GuruFocus Article or News written by insider and the topic is about:
Unusual Options Activity Insight: Catalent
On Monday, shares of Catalent (NYSE:CTLT) saw unusual options activity. After the option alert, the stock price moved up to $121.14. Sentiment: …
Tarsus Pharmaceuticals, Inc. Appoints Pharmaceutical And Healthcare Industry Leader Rosemary A. Crane To Board Of Directors
Ms. Crane brings over 30 years of experience in executive leadership, commercialization, and business development in the pharmaceutical and healthcare
Were Hedge Funds Right About Piling Into Caesars Entertainment Inc. (CZR)?
In this article we are going to use hedge fund sentiment as a tool and determine whether Caesars Entertainment Inc. (NASDAQ:CZR) is a good investment right now.
Cell & Gene Therapy Manufacturing Services Research Report 2021
/PRNewswire/ — The “Global Cell & Gene Therapy Manufacturing Services Market by Type (Allogeneic, Autologous, Viral Vector, Non-viral vector), Indication…
Global Drug Delivery Systems (DDS) Markets 2021-2027 – Increasing R&D Expenditures Of Innovator Companies And The Trend Of Patent Portfolio Expansion
DUBLIN, July 29, 2021 /PRNewswire/ — The
2 Stocks Insiders Are Buying
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this …
PharmAust makes progress in the quarter as it lays the foundation for commercialisation
Special Report: PharmAust has had a busy and productive quarter, setting the foundations for the commercialisation of its lead drug, monepantel.
Were Hedge Funds Right About Amcor plc (AMCR)?
Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession…
Were Hedge Funds Right About Rogers Communications Inc. (RCI)?
The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the first quarter,…
Monday Sector Laggards: Healthcare, Technology & Communications
Catalent (CTLT) Boosts Portfolio Via Launch of GPEx Lightning
Catalent's (CTLT) latest product is aimed at improving customer service by speeding up the drug substance development process.
Catalent plans $100 mln expansion at vaccine plant in Italy
Catalent Inc plans a $100 million expansion of its plant in Agnani, Italy, where the contract drug manufacturer is currently filling millions of vials of…
ETFs with Investments in SP500 Winners of 7
Three ETF's per winner (when available) ETF Ticker | % invested in Winner | ETF Full Name Industrials: ETFs investing in Generac Holdings Inc. PRN- …
Should I Avoid Expeditors International of Washington (EXPD)?
In this article we will analyze whether Expeditors International of Washington (NASDAQ:EXPD) is a good investment right now by following the lead of some…
Do Hedge Funds Love Affirm Holdings, Inc. (AFRM)?
With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred…
Global In Vitro Toxicology Testing Market is Estimated to Grow at a CAGR of 11.2% from 2021 to 2030
In Vitro Toxicology Testing Market, by Product and Service (Consumables, Assays, Equipment, Software, and Services), Methods (Cellular Assays, Biochemical…
Catalent Inc (CTLT): Price Down $-0.42 (-0.38)% Over Past Day, Up $0.25 (0.23)% Over Past Hour
This Therapeutics Company Is Eyeing Zero Competition for the Next 5 Years
If production setbacks can be avoided, gains should be in sight.
Blister Packaging Market Prices will increase by 3%-6% by 2024 | SpendEdge
/PRNewswire/ — SpendEdge has been monitoring the Blister Packaging will have an incremental spend of 6 Billion during 2020-2024. The report offers an…
Catalent (CTLT) to Enhance Its Portfolio via RheinCell Buyout
Catalent (CTLT) expects to strengthen its position in new therapeutic areas and boost its cell therapy portfolio via the latest acquisition.
Novo A Buys Spruce Biosciences Inc, Alibaba Group Holding, Kinnate Biopharma Inc, Sells Catalent Inc, Inogen Inc, Inozyme Pharma Inc
GuruFocus Article or News written by insider and the topic is about:
COVID-Impfung ohne Spritze – ein offenes Rennen
Wer ein Vakzine zum Schlucken zustandebringt, der knackt den Jackpot. Denn in der armen Welt sind die heutigen Vakzine nicht massentauglich.
Khan's Watchlist for 04/12/21-04/16/21 : stocks
Good morning everyone, here are my new ideas for the next week. As usual, the tickers below don't include the charts with my levels, drawings, and …
ACOR Rises On Restructuring, ALXN Pauses COVID-19 Trial, SYBX On Watch
Today's Daily Dose brings you news about Acorda's restructuring; Alexion's decision to pause its COVID-19 trial; and analyst's rating on Synlogic..
Contract Development and Manufacturing Organization Industry in APAC to 2030 – Key Drivers, Restraints and Challenges
DUBLIN, Jan. 13, 2021 /PRNewswire/ — The 'Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market 2020-2030…
Contract Development And Manufacturing Organization Industry In APAC To 2030 – Key Drivers, Restraints And Challenges
DUBLIN, Jan. 13, 2021 /PRNewswire/ — The “Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market 2020-2030 by Category,
The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Jan. 12) …
Virus Surge Ends Seven Months of U.S. Jobs Growth
The U.S. shed 140,000 jobs in December as a resurgence of the virus hit restaurants, ending seven months of job growth and weakening the economy.
Looking for a Growth Stock? 3 Reasons Why Catalent (CTLT) is a Solid Choice
Catalent (CTLT) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Moderna : Provides COVID-19 Vaccine Supply Update
Raises lower end of global manufacturing plan for 2021 from 500 million doses previously to 600 million doses
Continues to invest and hire in order to deliver up to 1 billion doses in 2021
… | January 4, 2021
Global Pharmaceuticals Contract Development & Manufacturing Market (2020 to 2025) – by Service, End-user and Geography
/PRNewswire/ — The “Global Pharmaceuticals Contract Development & Manufacturing Market (2020-2025) by Service, End User, Geography and the Impact of Covid-19…
Covid-19 Vaccines Are in High Demand, but Thousands More Workers Are Needed to Make Them
Contract-manufacturing companies working with Pfizer, Moderna and AstraZeneca to accelerate the global availability of coronavirus shots are struggling with a shortage of their own—the staff to meet the production push.